1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Norway
NORWAY 1
HEALTHCARE SYSTEM1
Facts and Figures1
Market Indicators2
Provision and Funding4
National Insurance Scheme4
Regulation and Provision 5
PRICING6
Prescription Drugs6
Applications7
Pricing Rules7
Timeline8
Generic Drugs8
Pricing Rules8
Biosimilars9
Hospital Drugs9
LIS9
National Procurement of Hospital Supplies and Services11
OTC Drugs11
REIMBURSEMENT11
Admission to Reimbursement11
Applications11
Procedure13
High-cost Drugs13
Reimbursement Contracts14
Timelines14
Reimbursement Categories14
Reimbursement Schedules15
Reforms16
Reimbursement Prices16
Stepped-price System16
Hospital Reimbursement19
Formularies19
Funding19
H-resept20
Changes in Reimbursement Status20
Hepatitis C Drugs21
Changes in Reimbursement Prices22
NoMA22
Manufacturers22
PHARMACOECONOMICS 23
Pharmacoeconomic Requirements23
Role in Reimbursement Decisions23
Guidelines23
HTA System for Specialist Drugs24
PRICE BUILD UP27
Wholesalers27
Margins27
Background27
Retail Pharmacies29
Margins29
Financial Incentives30
Sales Tax30
Background30
Dispensing Doctors33
Sales Tax33
COST CONTAINMENT33
Industry Paybacks33
Promotional Costs33
Promotion 33
Advertising34
Supervision 35
Patient Co-payments35
Pharmaceuticals35
Healthcare36
Co-payment Ceilings37
Prescribing Controls37
Prescribing Budgets37
Preferred Drug Guidelines38
National Guidelines38
Other Guidance39
Prescription Monitoring40
E-prescriptions40
Generics40
Substitution40
INN Prescribing42
Analogous Process Patents42
Rx-to-OTC Switches43
Parallel Trade43
FUTURE DEVELOPMENTS44
Outlook44
High-cost Drugs44
Overhaul of Reimbursement Categories44
NAMES and ADDRESSES44

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

OpportunityAnalyzer: Myelofibrosis - Opportunity Analysis and Forecasts to 2025 Summary Myelofibrosis (MF) is a rare blood disorder, which is characterized by bone marrow fibrosis. Currently, there is ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.